Celgene Corp.’s president and chief operating officer Jacqualyn Fouse, Ph.D., has decided to retire, effective June 30, 2017. She will continue to serve until April 1, and through June 30, she will serve as a strategic advisor to the management team. Scott Smith has been promoted to succeed Dr. Fouse, effective April 1, 2017. Also, Terrie Curran has been promoted to president, Global Inflammation & Immunology (I&I) Franchise, effective April 1. Dr. Fouse joined Celgene in 2010 as chie...